PRELP and retinoblastoma: Recently, we demonstrated that PRELP has the ability to activate mesenchymal-to-epithelial transition (MET), resulting in the enhancement in bladder epithelial cell-cell and retinoblastoma cells (Papadaki et al., 2020; Hopkins et al., 2022).